Modular Medical, Inc. Logo

Modular Medical, Inc.

MODD

(1.0)
Stock Price

1,39 USD

-177.42% ROA

-246.01% ROE

-4.04x PER

Market Cap.

69.355.782,00 USD

13.72% DER

0% Yield

-2066.85% NPM

Modular Medical, Inc. Stock Analysis

Modular Medical, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Modular Medical, Inc. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (12%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

3 PBV

The stock's PBV ratio (1.52x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

4 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

5 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

6 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

7 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

8 ROE

Negative ROE (-159.64%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

9 ROA

The stock's ROA (-103.38%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

10 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

11 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

Modular Medical, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Modular Medical, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Modular Medical, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Modular Medical, Inc. Revenue
Year Revenue Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%
2024 0 0%
2025 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Modular Medical, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 332.642 100%
2019 1.882.345 82.33%
2020 3.034.152 37.96%
2021 4.083.303 25.69%
2022 7.729.240 47.17%
2023 9.061.744 14.7%
2024 11.920.000 23.98%
2024 12.880.000 7.45%
2025 12.820.000 -0.47%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Modular Medical, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2001 20.000
2002 20.000 0%
2003 20.000 0%
2004 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 10.920 100%
2014 10.772 -1.37%
2015 16.115 33.16%
2016 13.163 -22.43%
2017 29.418 55.26%
2018 331.661 91.13%
2019 694.954 52.28%
2020 2.313.870 69.97%
2021 3.253.412 28.88%
2022 7.197.162 54.8%
2023 4.816.567 -49.43%
2024 4.840.000 0.48%
2024 4.200.000 -15.24%
2025 4.060.000 -3.45%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Modular Medical, Inc. EBITDA
Year EBITDA Growth
2001 -30.000
2002 -30.000 0%
2003 -10.000 -200%
2004 0 0%
2004 -6.207 100%
2005 -14.289 56.56%
2006 -8.906 -60.44%
2007 -6.482 -37.4%
2008 -6.716 3.48%
2009 -9.400 28.55%
2010 -7.668 -22.59%
2011 -9.174 16.42%
2012 -9.513 3.56%
2013 -10.920 12.88%
2014 -10.772 -1.37%
2015 -16.115 33.16%
2016 -13.163 -22.43%
2017 -91.051 85.54%
2018 -664.303 86.29%
2019 -2.562.831 74.08%
2020 -5.283.842 51.5%
2021 -7.154.744 26.15%
2022 -14.439.992 50.45%
2023 -13.724.937 -5.21%
2024 -16.380.000 16.21%
2024 -17.103.000 4.23%
2025 -15.736.000 -8.69%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Modular Medical, Inc. Gross Profit
Year Gross Profit Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 -1.861 100%
2019 -14.468 87.14%
2020 -35.431 59.17%
2021 -181.841 80.52%
2022 -196.921 7.66%
2023 -355.446 44.6%
2024 0 0%
2024 -768.000 100%
2025 -1.144.000 32.87%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Modular Medical, Inc. Net Profit
Year Net Profit Growth
2001 -30.000
2002 -30.000 0%
2003 -10.000 -200%
2004 0 0%
2004 -6.207 100%
2005 -14.289 56.56%
2006 -8.906 -60.44%
2007 -6.482 -37.4%
2008 -6.716 3.48%
2009 -9.400 28.55%
2010 -7.668 -22.59%
2011 -9.174 16.42%
2012 -17.492 47.55%
2013 -20.790 15.86%
2014 -22.794 8.79%
2015 -30.994 26.46%
2016 -31.084 0.29%
2017 -106.559 70.83%
2018 -659.246 83.84%
2019 -2.539.498 74.04%
2020 -5.320.873 52.27%
2021 -7.377.976 27.88%
2022 -18.632.761 60.4%
2023 -13.878.936 -34.25%
2024 -16.732.000 17.05%
2024 -17.470.000 4.22%
2025 -16.547.996 -5.57%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Modular Medical, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 -1 0%
2021 -1 100%
2022 -3 50%
2023 -1 -100%
2024 -1 0%
2024 -1 0%
2025 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Modular Medical, Inc. Free Cashflow
Year Free Cashflow Growth
2001 -50.000
2002 -50.000 0%
2003 -10.000 -400%
2004 0 0%
2004 -84 100%
2005 -76 -10.53%
2006 0 0%
2007 0 0%
2008 -6.716 100%
2009 0 0%
2010 0 0%
2011 0 0%
2012 -17.492 100%
2013 0 0%
2014 0 0%
2015 0 0%
2016 -10.663 100%
2017 -94.810 88.75%
2018 -806.463 88.24%
2019 -1.885.058 57.22%
2020 -4.355.628 56.72%
2021 -6.018.331 27.63%
2022 -10.314.292 41.65%
2023 -12.649.395 18.46%
2024 -3.622.000 -249.24%
2024 -15.652.000 76.86%
2025 -4.390.000 -256.54%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Modular Medical, Inc. Operating Cashflow
Year Operating Cashflow Growth
2001 -40.000
2002 -40.000 0%
2003 -10.000 -300%
2004 0 0%
2004 -84 100%
2005 -76 -10.53%
2006 0 0%
2007 0 0%
2008 -6.716 100%
2009 0 0%
2010 0 0%
2011 0 0%
2012 -17.492 100%
2013 0 0%
2014 0 0%
2015 0 0%
2016 -10.663 100%
2017 -94.810 88.75%
2018 -791.131 88.02%
2019 -1.807.934 56.24%
2020 -4.094.839 55.85%
2021 -5.908.662 30.7%
2022 -10.259.528 42.41%
2023 -11.011.644 6.83%
2024 -3.277.000 -236.03%
2024 -13.952.000 76.51%
2025 -3.548.000 -293.24%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Modular Medical, Inc. Capital Expenditure
Year Capital Expenditure Growth
2001 10.000
2002 10.000 0%
2003 0 0%
2004 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 15.332 100%
2019 77.124 80.12%
2020 260.789 70.43%
2021 109.669 -137.8%
2022 54.764 -100.26%
2023 1.637.751 96.66%
2024 345.000 -374.71%
2024 1.700.000 79.71%
2025 842.000 -101.9%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Modular Medical, Inc. Equity
Year Equity Growth
2002 -80.000
2003 -80.000 0%
2004 -10.000 -700%
2004 -10.974 8.88%
2005 -23.763 53.82%
2006 -31.169 23.76%
2007 -37.651 17.22%
2008 -44.367 15.14%
2009 -53.767 17.48%
2010 -61.435 12.48%
2011 -70.609 12.99%
2012 -88.101 19.85%
2013 -108.891 19.09%
2014 -131.685 17.31%
2015 -162.679 19.05%
2016 -193.763 16.04%
2017 1.297.980 114.93%
2018 4.318.981 69.95%
2019 6.474.057 33.29%
2020 2.878.422 -124.92%
2021 -1.275.149 325.73%
2022 8.836.790 114.43%
2023 5.075.976 -74.09%
2024 11.535.000 56%
2024 7.938.000 -45.31%
2025 8.016.000 0.97%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Modular Medical, Inc. Assets
Year Assets Growth
2002 0
2003 0 0%
2004 0 0%
2004 76 100%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 2.500 100%
2016 0 0%
2017 1.372.400 100%
2018 4.334.452 68.34%
2019 6.652.986 34.85%
2020 3.858.551 -72.42%
2021 2.248.171 -71.63%
2022 9.846.446 77.17%
2023 7.245.248 -35.9%
2024 13.807.000 47.52%
2024 10.059.000 -37.26%
2025 10.072.000 0.13%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Modular Medical, Inc. Liabilities
Year Liabilities Growth
2002 0
2003 0 0%
2004 10.000 100%
2004 11.050 9.5%
2005 23.763 53.5%
2006 31.169 23.76%
2007 37.651 17.22%
2008 44.367 15.14%
2009 53.767 17.48%
2010 61.435 12.48%
2011 70.609 12.99%
2012 88.101 19.85%
2013 108.891 19.09%
2014 131.685 17.31%
2015 165.179 20.28%
2016 193.763 14.75%
2017 74.420 -160.36%
2018 15.471 -381.03%
2019 178.929 91.35%
2020 980.129 81.74%
2021 3.523.320 72.18%
2022 1.009.656 -248.96%
2023 2.169.272 53.46%
2024 2.272.000 4.52%
2024 2.121.000 -7.12%
2025 2.056.000 -3.16%

Modular Medical, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.03
Net Income per Share
-0.53
Price to Earning Ratio
-4.04x
Price To Sales Ratio
76.89x
POCF Ratio
-5.05
PFCF Ratio
-4.21
Price to Book Ratio
9
EV to Sales
72.51
EV Over EBITDA
-3.79
EV to Operating CashFlow
-4.58
EV to FreeCashFlow
-3.97
Earnings Yield
-0.25
FreeCashFlow Yield
-0.24
Market Cap
0,07 Bil.
Enterprise Value
0,07 Bil.
Graham Number
1.68
Graham NetNet
0.09

Income Statement Metrics

Net Income per Share
-0.53
Income Quality
0.8
ROE
-2.28
Return On Assets
-2.13
Return On Capital Employed
-2.5
Net Income per EBT
1
EBT Per Ebit
0.99
Ebit per Revenue
-20.85
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
5.01
Research & Developement to Revenue
14.94
Stock Based Compensation to Revenue
3.05
Gross Profit Margin
0.28
Operating Profit Margin
-20.85
Pretax Profit Margin
-20.67
Net Profit Margin
-20.67

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.42
Free CashFlow per Share
-0.49
Capex to Operating CashFlow
-0.15
Capex to Revenue
2.4
Capex to Depreciation
2.93
Return on Invested Capital
-1.97
Return on Tangible Assets
-1.77
Days Sales Outstanding
57.46
Days Payables Outstanding
203.71
Days of Inventory on Hand
0
Receivables Turnover
6.35
Payables Turnover
1.79
Inventory Turnover
0
Capex per Share
0.06

Balance Sheet

Cash per Share
0,15
Book Value per Share
0,24
Tangible Book Value per Share
0.24
Shareholders Equity per Share
0.24
Interest Debt per Share
0.03
Debt to Equity
0.14
Debt to Assets
0.11
Net Debt to EBITDA
0.23
Current Ratio
4.03
Tangible Asset Value
0,01 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
8730000
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0.02

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Modular Medical, Inc. Dividends
Year Dividends Growth

Modular Medical, Inc. Profile

About Modular Medical, Inc.

Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California.

CEO
Mr. James E. Besser
Employee
39
Address
16772 W. Bernardo Drive
San Diego, 92127

Modular Medical, Inc. Executives & BODs

Modular Medical, Inc. Executives & BODs
# Name Age
1 Mr. Paul M. DiPerna
Founder, Chairman, President, Chief Financial Officer & Treasurer
70
2 Mr. James E. Besser
Chief Executive Officer
70
3 Mr. Kevin Schmid
Chief Operating Officer
70

Modular Medical, Inc. Competitors